Entera Bio Ltd
NASDAQ:ENTX
Balance Sheet
Balance Sheet Decomposition
Entera Bio Ltd
Current Assets | 11.3m |
Cash & Short-Term Investments | 11m |
Other Current Assets | 238k |
Non-Current Assets | 508k |
PP&E | 488k |
Other Non-Current Assets | 20k |
Current Liabilities | 1.1m |
Accounts Payable | 83k |
Accrued Liabilities | 1m |
Non-Current Liabilities | 288k |
Other Non-Current Liabilities | 288k |
Balance Sheet
Entera Bio Ltd
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash & Cash Equivalents |
1
|
4
|
12
|
8
|
15
|
9
|
25
|
12
|
11
|
|
Cash |
1
|
4
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash Equivalents |
0
|
0
|
0
|
8
|
15
|
9
|
25
|
12
|
11
|
|
Short-Term Investments |
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Assets |
2
|
5
|
12
|
12
|
16
|
9
|
25
|
13
|
11
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
Intangible Assets |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
3
N/A
|
6
+129%
|
13
+111%
|
13
+0%
|
17
+25%
|
10
-42%
|
26
+167%
|
13
-49%
|
12
-10%
|
|
Liabilities | ||||||||||
Accounts Payable |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accrued Liabilities |
0
|
0
|
1
|
0
|
1
|
2
|
3
|
1
|
1
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
1
|
3
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
1
|
11
|
2
|
2
|
5
|
2
|
3
|
1
|
1
|
|
Long-Term Debt |
21
|
16
|
37
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
7
|
5
|
5
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
28
N/A
|
32
+11%
|
45
+42%
|
3
-93%
|
5
+48%
|
2
-54%
|
3
+55%
|
1
-60%
|
1
+1%
|
|
Equity | ||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
28
|
28
|
34
|
39
|
52
|
70
|
82
|
96
|
104
|
|
Additional Paid In Capital |
2
|
2
|
3
|
49
|
63
|
78
|
105
|
107
|
115
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
26
N/A
|
25
+2%
|
32
-25%
|
10
N/A
|
12
+18%
|
8
-37%
|
23
+201%
|
12
-48%
|
10
-12%
|
|
Total Liabilities & Equity |
3
N/A
|
6
+129%
|
13
+111%
|
13
+0%
|
17
+25%
|
10
-42%
|
26
+167%
|
13
-49%
|
12
-10%
|
|
Shares Outstanding | ||||||||||
Common Shares Outstanding |
12
|
12
|
11
|
11
|
18
|
21
|
29
|
29
|
35
|